Invention Grant
US09353108B2 Tetrahydronaphthyridine somatostatin receptor 5 antagonists 有权
四氢萘并嘧啶生长抑素受体5拮抗剂

Tetrahydronaphthyridine somatostatin receptor 5 antagonists
Abstract:
A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.
Public/Granted literature
Information query
Patent Agency Ranking
0/0